Pediatric Therapy M&A and Capital Markets UpdateActivity Remains Resilient Through April 2026
- 4 days ago
- 3 min read
Updated: 3 days ago
By Luis F. Lopez, PhD, President of Mergium Advisors
Executive Summary
Despite ongoing operational headwinds in pediatric therapy—including staffing constraints, reimbursement pressure, and broader macroeconomic uncertainty—transaction activity through April 2026 has remained resilient.
Mergium Advisors’ proprietary tracking indicates:
11 M&A transactions completed in the first four months of 2026
9 transactions in Q1 alone, consistent with the quarterly run-rate observed since 2022
Continued dominance of private equity-backed platform acquisitions
Sustained investor interest in multi-disciplinary pediatric therapy models
At the same time, capital continues to flow into technology-enabled providers, particularly those leveraging virtual care and differentiated delivery models.
M&A Activity Overview
Transaction Volume by Quarter
Period | Number of Transactions |
Q1 2026 | 9 |
April 2026 | 2 |
Total (Jan–Apr 2026) | 11 |
👉 Observation:Q1 deal volume is in line with historical quarterly averages since 2022, indicating that buyer demand remains intact despite market uncertainty.

Transactions by Buyer Type
Buyer Type | Number of Transactions | % of Total |
PE-backed platform companies (add-ons) | 7 | 64% |
New private equity platform investments | 2 | 18% |
Strategic buyers (incl. non-profits) | 2 | 18% |
Total | 11 | 100% |
Key Trends in M&A Activity
1) PE-Backed Platforms Continue to Drive Consolidation
Private equity-backed platforms completed 7 add-on acquisitions, representing the majority of deal activity.
One notable transaction:
Ally Pediatric Therapy was sold by SBJ Capital to ACES. ACES is sponsored by General Atlantic.
Additionally:
Ally Pediatric Therapy had the largest footprint in the dataset (8 locations)
👉 This confirms a critical trend:
Consolidation in pediatric therapy continues to be driven primarily by existing platforms—not new entrants.
These buyers remain focused on:
Geographic expansion
Clinician density
Service line expansion
2) Continued (Selective) Entry of New Private Equity Capital
Two transactions involved new private equity platform investments, signaling that:
Institutional capital continues to target scaled, multi-disciplinary pediatric therapy businesses.
However, entry remains selective, with emphasis on:
Strong compliance infrastructure
Diverse payor mix
Scalable clinical and operational models
3) Interest in Multi-Disciplinary Models
Service Mix | Number of Transactions |
ABA-only | 1 |
Multi-disciplinary (ABA/OT/PT/ST) | 10 |
👉 Key takeaway:
Buyers looked for multi-disciplinary providers.
Drivers include:
Reduced reimbursement concentration risk
Cross-referral opportunities
Clinical integration
Improved scalability across markets
Alignment with evolving care models
4) Expansion of Care Delivery Models
Across transactions, targets included:
Clinic-based providers
In-home therapy models
School-based service providers
Community-based delivery platforms
👉 This reflects:
Growing buyer interest in flexible, multi-setting care delivery models aligned with family and payer preferences.
5) Integration of Behavioral Health Services
2 transactions involved providers offering pediatric counseling alongside therapy services
👉 This indicates:
Increasing convergence between pediatric therapy and mental health.
6) Strategic Buyers Remain Selectively Active
Two transactions involved strategic buyers:
Type of Strategic Buyer | Description |
Non-profit organization | Autism + mental health + IDD services |
School-based provider | ABA, OT, ST services |
👉 Insight:
Strategic buyers remain active in mission-driven and education-integrated models.
Capital Raising Activity (Private Placements)
Announced Capital Raises
Company | Amount Raised | Focus | Model |
Coral Care | $13M | Pediatric therapy (ST, OT, PT) | In-home, tech-enabled marketplace |
AnswersNow | $40M | Autism therapy | Virtual BCBA-led model |
Avela Health | ~$7M | Autism diagnostics & support | Virtual care |
Capital Markets Insight
The nature of these raises is telling:
Focus on technology-enabled delivery models
Strong interest in virtual autism services
Emphasis on parent-mediated and scalable care models
👉 This signals:
Venture capital is increasingly targeting innovation layers on top of traditional pediatric therapy services.
What This Means for Owners and Investors
For Practice Owners
Buyer demand remains strong, particularly from PE-backed platforms
Buyers interested in multi-disciplinary providers
Practices with:
Diverse payor mix
Strong compliance
Scalable operations
are best positioned for premium outcomes
For Investors
Platform expansion is driving deal flow so far this year
Continued opportunity in:
Add-on acquisitions
Multi-service integration strategies
For the Market
Pediatric therapy is in the middle of a more mature consolidation phase, characterized by:
Strategic platform expansion
Selective new capital deployment
Continued innovation through venture-backed models
Final Takeaway
Despite industry-specific and macroeconomic challenges:
The pediatric therapy M&A market remains active, disciplined, and structurally healthy.
Consolidation is ongoing
Capital is still available
Buyers are more selective—but still highly engaged
